Inactive Instrument

Analyst Reco. Signify Health, Inc.

Equities

SGFY

US82671G1004

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

UBS Downgrades Signify Health to Neutral From Buy, Adjusts Price Target to $30.50 From $27	22-09-07	MT
Guggenheim Downgrades Signify Health to Neutral From Buy	22-09-07	MT
Truist Securities Starts Signify Health at Hold With $30.50 Price Target	22-09-07	MT
BTIG Downgrades Signify Health to Neutral From Buy	22-09-07	MT
RBC Capital Adjusts Price Target on Signify Health Price Target to $30.50 From $20, Maintains Sector Perform Rating	22-09-06	MT
William Blair Downgrades Signify Health to Market Perform From Outperform	22-09-06	MT
Piper Sandler Downgrades Signify Health to Neutral From Overweight, Adjusts Price Target to $30.50 From $34	22-09-06	MT
Baird Downgrades Signify Health to Neutral From Outperform, Adjusts Price Target to $30.50 From $28	22-09-06	MT
JPMorgan Downgrades Signify Health to Neutral From Overweight, Adjusts Price Target to $30.50 From $32	22-09-06	MT
BTIG Starts Signify Health at Buy With $35 Price Target	22-08-31	MT
Wall Street Set for Losses as Rate Hike Fears Resurface Ahead of Jackson Hole	22-08-22	MT
Guggenheim Adjusts Signify Health's Price Target to $30 from $34, Maintains Buy Rating	22-08-17	MT
Deutsche Bank Adjusts Signify Health's Price Target to $27 From $30, Maintains Buy Rating	22-08-17	MT
UBS Adjusts Signify Health Price Target to $27 From $22, Maintains Buy Rating	22-08-08	MT
RBC Raises Price Target on Signify Health to $20 From $18, Maintains Sector Perform Rating	22-08-05	MT
Deutsche Bank Adjusts Signify Health's Price Target to $30 From $26, Maintains Buy Rating	22-08-05	MT
Piper Sandler Adjusts Signify Health's Price Target to $34 From $32, Reiterates Overweight Rating	22-08-05	MT
RBC Initiates Signify Health at Sector Perform With $18 Price Target, Expects 20%+ Revenue Growth, EBITDA Margins for Next 3+ Years	22-07-29	MT
Piper Sandler Adjusts Signify Health's Price Target to $32 From $27, Reiterates Overweight Rating	22-06-06	MT
Goldman Sachs Adjusts Signify Health Price Target to $20 From $22, Maintains Buy Rating	22-05-26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Signify Health, Inc.

Equities

SGFY

US82671G1004

Analyst Reco.

Filters